DJIA 17,827.75 12.81 0.07%
NASDAQ 4,787.32 0.00 0.00%
S&P 500 2,072.83 5.80 0.28%
market minute promo

Rexahn Pharmaceuticals (NYSEMKT: RNN)

0.69 0.00 (-0.57%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

RNN $0.69 -0.57%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $0.69
Previous Close $0.69
Daily Range $0.68 - $0.70
52-Week Range $0.39 - $1.85
Market Cap $122.3M
P/E Ratio -6.86
Dividend (Yield) $0.00 (0.0%)
Volume 209,286
Average Daily Volume 605,066
Current FY EPS -$0.12

Sector

Healthcare

Industry

Drugs

Rexahn Pharmaceuticals (RNN) Description

Rexahn Pharmaceuticals Inc. is a clinical stage biopharmaceutical company developing and seeking to deliver novel cures for cancer and disorders of the central nervous system (CNS) to patients worldwide. Website: http://www.rexahn.com/

News & Commentary

This Week in Biotech: NW Bio Soars While Geron Goes Geronimo

Two early-stage study results, a rare hospital exemption approval in Germany, and a devastating full clinical hold for one biotech are among this week's top biotech stories.

Update: Rexahn Q3 Earnings, Bull Thesis Reiterated

Events for the Week of Nov. 17-21, 2014

Rexahn's New Nanotechnology Patent Creates Next-Generation Docetaxel, Gemcitabine And Cisplatin

Rexahn Pharmaceuticals (RNN) Jumps: Stock Gains 10.2% - Tale of the Tape

Rexahn Update: A Partnership Is All The More Likely

Rexahn Pharmaceuticals (RNN) Jumps: Stock Rises 9.6% - Tale of the Tape

Rexahn Receives A Notice of Allowance From The U.S. Patent And Trademark Office For A Novel Targeted

Rexahn Receives A Notice of Allowance From The U.S. Patent And Trademark Office For A Novel Targeted Cancer Drug Delivery Platform

Update: Rexahn Q2 Earnings - Stock Down, But My Optimism Remains Intact

What Falling Estimates & Price Mean for Rexahn Pharmaceuticals (RNN) - Tale of the Tape

Rexahn Pharmaceuticals (RNN) Jumps: Stock Surges 19.2% - Tale of the Tape

See More RNN News...

RNN's Top Competitors

RNN $0.69 (-0.57%)
Current stock: RNN
AMGN $164.72 (1.53%)
Current stock: AMGN
GILD $100.30 (-0.80%)
Current stock: GILD
BIIB $304.92 (-0.16%)
Current stock: BIIB